Skip to content

Strengthening Program for Foot-ankle Muscles in People With Knee Osteoarthritis

Effects of a Strengthening Program for Foot-ankle Muscles in Clinical Aspects and Gait Biomechanics of People With Knee Osteoarthritis: a Randomized Blinded Clinical Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04154059
Enrollment
30
Registered
2019-11-06
Start date
2020-01-27
Completion date
2023-08-04
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

Rehabilitation, Arthrosis, Therapeutic exercises, Feet

Brief summary

The main objective of this trial is To evaluate the effect of an ankle and foot muscle strengthening program on pain, analgesic consumption, functionality, and lower limb biomechanics during gait in individuals with knee osteoarthritis.

Detailed description

A randomized controlled trial will be performed with 76 patients with knee osteoarthritis. The participants will be randomly assigned into either a control group (no exercises; they will keep their recommended clinical treatment) or an intervention group which will receive 8-week physical therapy exercises, three times per week, under the supervision of a physiotherapist. Every exercise has its own progression depending on the subjects' execution, increasing in intensity and difficulty. The subjects will be evaluated in 3 different moments (Baseline, immediately after treatment and 8 weeks follow-up). The hypothesis of this study is that the intervention group will decrease pain and medication intake, and improve functional performance, increase isometric strength of the feet and production of beneficial biomechanical changes during walking compared to the control group.

Interventions

OTHERIntervention Group

Patients will receive a physical therapy intervention for strengthening, stretching and functional training of ankle and foot.

Sponsors

University of Sao Paulo
CollaboratorOTHER
Universidade Federal de Sao Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Knee osteoarthritis (KOA) based on clinical and radiological criteria of American College of Reumathology; * KOA (Grade II and III - Radiological classification of Kellgreen and Laurence) in medial compartment of knee; * Knee pain between 30 and 80 on the visual analogue scale; * BMI \< 35 kg/m2.

Exclusion criteria

* KOA isolated (Grade II and III - Radiological classification of Kellgreen and Laurence) in lateral compartment of knee; * Lower limb strength training (3 times per week); * Wear minimalist shoes for at least 6 hours a day and 5 days a week; * Physical therapy in the previous 3 months; * Having received steroid injections and hyaluronic acid intra-articular knee in previous periods of three and six months respectively; * Previous history of surgery on knees, ankles and hips in the last 2 years; * Neurological disease; * Inflammatory arthritis (eg. rheumatoid arthritis); * Asymptomatic OA of one or both knees.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline The WOMAC (Western Ontario and McMaster Universities) Pain Subscale at 8 and 16 weeks.Baseline, 8 weeks and 16 weeks.The WOMAC pain subscale consists of five questions (Likert Scale) relating to the patient's pain in everyday situations. The Likert Scale version used for all WOMAC items are: none, mild, moderate, severe, and extreme. The sum of all items of pain subscale ranges from 0 to 20. Higher scores indicate worse pain.

Secondary

MeasureTime frameDescription
Change from baseline WOMAC (Western Ontario and McMaster Universities) Physical Function Subscale at 8 and 16 weeks.Baseline, 8 weeks and 16 weeks.he physical function subscale included in the WOMAC index consists of seventeen questions (Likert Scale) relating to the patient's physical activities, or skills to move out and take care of themselves. The Likert Scale version used for all WOMAC items are: none, mild, moderate, severe, and extreme. The sum of all items of physical function subscale ranges from 0 to 68. Higher scores on the physical function WOMAC subscale indicate worse functional limitations.
Change from baseline WOMAC (Western Ontario and McMaster Universities) Total Score at 8 and 16 weeksBaseline, 8 weeks and 16 weeks.The WOMAC total score is the sum of all subscale (pain, function and stiffness) (Likert Scale) relating to the patient's physical activities, or skills to move out and take care of themselves. The Likert Scale version used for all WOMAC items are: none, mild, moderate, severe, and extreme.
30-second Chair Stand TestBaseline, 8 weeks and 16 weeks.The maximum number of chair stand repetitions possible in a 30 second period.
9-step Stair Climb TestBaseline, 8 weeks and 16 weeks.The time (in seconds) it takes to ascend and descend a flight of stairs. Where possible, the 9-step stair test with 20cm (8 inch) step height and handrail is recommended.
40m (4x10m) Fast Paced Walk TestBaseline, 8 weeks and 16 weeks.A test of walking speed over short distances and changing direction during walking. A fast-paced walking test that is timed over 4 x 10m for a total 40 m (convert time to speed).
Change from baseline WOMAC (Western Ontario and McMaster Universities) Stiffness Subscale at 8 and 16 weeks.Baseline, 8 weeks and 16 weeks.The stiffness subscale included in the WOMAC index consists of two questions (Likert Scale) relating articular function of the patient. The Likert Scale version used for all WOMAC items are: none, mild, moderate, severe, and extreme. The sum of all items of the stiffness subscale ranges from 0 to 8. Higher scores on the stiffness WOMAC subscale indicate worse articular function.
Foot Kinematics during gaitBaseline, 8 weeks and 16 weeks.Foot joints and plantar arch motion during gait.The kinematics outcomes will be evaluate by mean inverse dynamics approach. To this procedure, we will use the kinematics data of the lower limbs assessed with six infrared cameras and the ground reaction force evaluated by mean a force platform.
Knee joint moments during gaitBaseline, 8 weeks and 16 weeks.Peak joint moment by inverse dynamic calculations. To this procedure, we will use the kinematics and kinetics data of the lower limbs assessed with six infrared cameras and the ground reaction force evaluated by mean a force platform.
Global Rating of Change Scale8 weeks and 16 weeks.GRCS assesses the clinical change perceived by the patient by comparing the onset of symptoms before and after treatment. With respect to your knee injury, how do you describe your situation now compared to the start of treatment? This numerical scale consists of 11 points (from -5 to +5: -5, extremely worse; 0, unchanged; +5, fully recovered). Higher scores indicate better recovery from the condition.
Paracetamol intakeBaseline, 8 weeks and 16 weeks.Paracetamol intake (500 mg), number of tablets per month.
Foot strengthBaseline, 8 weeks and 16 weeks.Hallux and lesser toes force measured by a pressure plate

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026